Yasuhiro Yanagita

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

Norikazu Masuda, Soo-Jung Lee, Shoichiro Ohtani et al. · New England Journal of Medicine · 2017 · 1.9K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

Mitsue Saito, Kenjiro Aogi, Ikuo Sekine et al. · The Lancet Oncology · 2009 · 434 citations

Medicine, Oncology, Pharmacology +14

Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial

Norikazu Masuda, Yasuaki Sagara, Takayuki Kinoshita et al. · The Lancet Oncology · 2012 · 178 citations

Medicine, Oncology, Pharmacology +13

Lysophosphatidic Acid (LPA) in Malignant Ascites Stimulates Motility of Human Pancreatic Cancer Cells through LPA1

Takayuki Yamada, Kōichi Sato, Mayumi Komachi et al. · Journal of Biological Chemistry · 2004 · 176 citations · Full text

Medicine, Oncology, Pharmacology +15